title: [Bronchoconstriction in administration of ACE inhibitors].
abstract: The aim of the study was assessment of bronchial capacity in the treatment with ACE inhibitors. 92 patients with essential hypertension stage I-II (mean age 52 years), ischemic heart disease and bronchial asthma (a mild, moderate and severe course) in a relative remission were treated for arterial hypertension with ACE inhibitors enalapril and diroton. Enalapril improved cough indices by 38.3%, diroton--by 13.3%. This was accompanied by a rise in the level of natural antibodies to bradikinin.
authors.forename: O V
authors.initials: OV
authors.lastname: Aleksandrov
authors.forename: M A
authors.initials: MA
authors.lastname: Miagkova
authors.forename: T V
authors.initials: TV
authors.lastname: Kondrashova
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000906:Antibodies / Q000187:drug effects; D001249:Asthma / Q000150:complications* / Q000276:immunology / Q000503:physiopathology*; D001920:Bradykinin / Q000187:drug effects / Q000276:immunology; D016084:Bronchoconstriction / Q000187:drug effects* / Q000276:immunology; D003371:Cough / Q000276:immunology / Q000503:physiopathology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications / Q000188:drug therapy*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000906:Antibodies; D001920:Bradykinin